Warp Sciences
United States · AI · Robotics
Warp Sciences combines chemistry, AI and robotics to help drug discovery teams make and test molecules in the United States.
A chemistry partner for drug discovery
Warp Sciences is a chemistry contract research organisation in South San Francisco, California. It works with biotech and pharmaceutical research teams that need compounds made and tested as they refine prospective medicines.
The company brings chemists, AI researchers and roboticists into laboratories designed for increasing automation. Chemists guide experimental work while data from successive experiments helps improve the models and workflows used in the lab.
Team and development
Kevin Weil leads Warp as chief executive, alongside chief scientific officer Sol Reisberg, chief operating officer DJ Patil and chief technology officer Manohar Paluri. Warp is working with a small number of design partners as it builds capacity.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $215M | Lightspeed — LeadIVP — ParticipantLux Capital — ParticipantMayfield — ParticipantMenlo Ventures — ParticipantPremji Invest — Participant |